The American company Eli Lilly will transfer its Russian business to the Swiss company Swixx Biopharma. Previously, Swixx Biopharma received the business of another American pharmaceutical company, Bristol-Myers Squibb (BMS). The American Eli Lilly banned the Swiss Swixx BioPharma, which a year ago bought Eli Lilly’s business in Russia, from supplying Humalog insulin to the country.
June 12, 2024 | The American Eli Lilly has banned the supply of Humalog insulin to Russia |